Please see full Prescribing Information, including Boxed Warning, or visit https://www.rxabbvie.com/pdf/linzess_pi.pdf.
US-LIN-230215
References: 1. LINZESS. Prescribing Information. AbbVie Inc.; 2023. 2. Di Lorenzo C, Nurko S, Rodriguez-Araujo G, et al. Linaclotide safety and efficacy in children aged 6-17 years with functional constipation: a phase 3, pivotal, randomized, placebo-controlled trial. Presented at: Digestive Disease Week (DDW); May 6-9, 2023; Chicago, IL. Oral Presentation 145.